SPY412.17-3.04 -0.73%
DIA338.12-2.63 -0.77%
IXIC13,786.27-128.50 -0.92%

Credit Suisse Maintains Neutral on Solid Biosciences, Raises Price Target to $8

Credit Suisse analyst Martin Auster maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and raises the price target from $7 to $8.

· 03/16/2021 09:33
Credit Suisse analyst Martin Auster maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and raises the price target from $7 to $8.